Skip to main content
SOPHiA GENETICS logo

SOPHiA GENETICS — Investor Relations & Filings

Ticker · SOPH ISIN · CH1125843347 LEI · 506700H1GPU9GGM8W895 US Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 296 across all filing types
Latest filing 2026-06-04 Regulatory Filings
Country CH Switzerland
Listing US SOPH

About SOPHiA GENETICS

https://www.sophiagenetics.com

SOPHiA GENETICS is an AI-powered healthcare technology company focused on advancing data-driven medicine. Its core offering is the SOPHiA DDM™ platform, a cloud-based system that utilizes artificial intelligence to analyze complex genomic and multimodal health data. The platform provides actionable insights to healthcare professionals, supporting diagnosis and treatment primarily in the fields of oncology and rare or inherited diseases. By connecting a global network of healthcare institutions, SOPHiA GENETICS creates a collective intelligence that aims to improve analytical accuracy and democratize access to precision medicine, ultimately enhancing patient outcomes worldwide.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings Classification · 89% confidence The document is a SEC Form 6-K (current report by a foreign private issuer) including a press release exhibit. It is a regulatory submission rather than an annual or interim report, earnings release, or management discussion. Per the guidelines, Form 6-K filings fall under general regulatory filings (RNS).
2026-06-04 English
6-K
Report Publication Announcement Classification · 98% confidence The document is a Form 6-K notice by a foreign private issuer announcing that it has published its 2025 ESG Impact Summary, with the report available on its website. There is no substantive ESG content included; it simply announces the publication of a report (Exhibit 99.1). This matches the definition of a Report Publication Announcement (RPA).
2026-05-19 English
6-K - SOPHiA GENETICS SA (0001840706) (Filer)
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form 6-K by a foreign issuer furnishing the invitation, meeting notice, and proxy cards for its Annual General Meeting. These exhibits constitute proxy solicitation/information materials rather than the meeting presentation itself or a standalone annual report. Therefore it best fits the Proxy Solicitation & Information Statement category (PSI).
2026-05-08 English
6-K - SOPHiA GENETICS SA (0001840706) (Filer)
Regulatory Filings Classification · 93% confidence The document is clearly a Form 6-K filed by a foreign private issuer (SOPHiA GENETICS SA) under the Securities Exchange Act. It serves as a regulatory submission incorporating exhibits (interim financial statements, MD&A, press release) rather than being the report itself. Form 6-K is a general regulatory filing and does not fit into more specific categories like an annual report or earnings release. Therefore, it is best classified under Regulatory Filings (RNS).
2026-05-05 English
4 - SOPHiA GENETICS SA (0001840706) (Issuer)
Director's Dealing
2026-03-20 English
4 - SOPHiA GENETICS SA (0001840706) (Issuer)
Director's Dealing
2026-03-20 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.